Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry

Objective: To evaluate effectiveness, tolerability and safety of an oromucosal spray containing Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), as add-on treatment in patients with severe chronic pain (SCP). Methods: Exploratory analysis of anonymized 12-week routine/open-label data provided by...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueberall, Michael A, Essner, Ute, Mueller-Schwefe, Gerhard HH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535492/
https://www.ncbi.nlm.nih.gov/pubmed/31190969
http://dx.doi.org/10.2147/JPR.S192174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535492/
https://www.ncbi.nlm.nih.gov/pubmed/31190969
http://dx.doi.org/10.2147/JPR.S192174

Ejemplares similares